Overview Auto Stem Cell Transplant for Lymphoma Patients Status: Recruiting Trial end date: 2026-04-30 Target enrollment: Participant gender: Summary This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive. Phase: Phase 2 Details Lead Sponsor: Masonic Cancer Center, University of MinnesotaTreatments: CarmustineCyclophosphamideCytarabineEtoposideEtoposide phosphateMelphalan